The basis for non-canonical ROK family function in the N-acetylmannosamine kinase from the pathogen Staphylococcus aureus by Coombes, David et al.
This is a repository copy of The basis for non-canonical ROK family function in the N-
acetylmannosamine kinase from the pathogen Staphylococcus aureus.




Coombes, David, Davies, James S, Newton-Vesty, Michael C et al. (9 more authors) 
(2020) The basis for non-canonical ROK family function in the N-acetylmannosamine 
kinase from the pathogen Staphylococcus aureus. The Journal of biological chemistry. pp. 





Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
The basis for non-canonical ROK family function in the
N-acetylmannosamine kinase from the pathogen
Staphylococcus aureus
Received for publication, August 8, 2019, and in revised form, December 31, 2019 Published, Papers in Press, January 15, 2020, DOI 10.1074/jbc.RA119.010526
X David Coombes‡, James S. Davies‡, Michael C. Newton-Vesty‡, Christopher R. Horne‡, X Thanuja G. Setty§¶,
X Ramaswamy Subramanian§, James W. B. Moir, X Rosmarie Friemann**‡‡, Santosh Panjikar§§¶¶,
Michael D. W. Griffin, X Rachel A. North‡1, and Renwick C. J. Dobson‡2
From the ‡Biomolecular Interaction Centre and School of Biological Sciences, University of Canterbury, Christchurch 8140, New
Zealand, the §Institute for Stem Cell Biology and Regenerative Medicine, NCBS, GKVK Campus, Bellary Road, Bangalore, Karnataka
560 065, India, ¶The University of Trans-Disciplinary Health Sciences and Technology (TDU), Bangalore, KA 560064, India, the
Department of Biology, University of York, Helsington, York YO10 5DD, United Kingdom, the **Department of Clinical
Microbiology, Sahlgrenska University Hospital, Guldhedsgatan 10A, 413 46 Gothenburg, Sweden, the ‡‡Centre for Antibiotic
Resistance Research (CARe), University of Gothenburg, 40530 Gothenburg, Sweden, the §§Department of Biochemistry and
Molecular Biology, Monash University, Clayton, Victoria 3800, Australia, the ¶¶Australian Synchrotron, ANSTO, Victoria 3168,
Australia, and the Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute,
University of Melbourne, Parkville, Victoria 3010, Australia
Edited by Joseph M. Jez
In environments where glucose is limited, some pathogenic
bacteriametabolize host-derived sialic acid as a nutrient source.
N-Acetylmannosamine kinase (NanK) is the second enzyme of
the bacterial sialic acid import and degradation pathway and
adds phosphate to N-acetylmannosamine using ATP to prime
themolecule for future pathway reactions. Sequence alignments
reveal that Gram-positive NanK enzymes belong to the
Repressor, ORF, Kinase (ROK) family, but many lack the
canonical Zn-binding motif expected for this function, and
the sugar-binding EXGHmotif is altered to EXGY. As a result,
it is unclear how they perform this important reaction. Here,
we study the Staphylococcus aureusNanK (SaNanK), which is
the first characterization of a Gram-positive NanK. We
report the kinetic activity of SaNanK along with the ligand–
free, N-acetylmannosamine–bound and substrate analog
GlcNAc–bound crystal structures (2.33, 2.20, and 2.20 Å reso-
lution, respectively). These demonstrate, in combination with
small-angleX-ray scattering, that SaNanK is a dimer that adopts
a closed conformation upon substrate binding. Analysis of the
EXGYmotif reveals that the tyrosine binds to theN-acetyl group
to select for the “boat” conformation of N-acetylmannosamine.
Moreover, SaNanK has a stacked arginine pair coordinated by
negative residues critical for thermal stability and catalysis.
These combined elements serve to constrain the active site and
orient the substrate in lieu of Zn binding, representing a signif-
icant departure from canonical NanK binding. This character-
ization provides insight into differences in the ROK family and
highlights a novel area for antimicrobial discovery to fight
Gram-positive and S. aureus infections.
Pathogenic bacteria import and utilize a wide variety of car-
bohydrates. In environments where glucose is limited, amino
sugars such as sialic acids are important nutrient sources. In
general, the bacterial sialic acid catabolic pathway is a validated
antimicrobial target (1–4), because sialic acids are scavenged
from mucins that coat the gastrointestinal and respiratory
tracts of humans (5) and are imported (6–8) and used by path-
ogenic bacteria as a carbon, nitrogen, and energy source when
they colonize these niches (1, 9–11). This is particularly the
case in mucosal surfaces, where the amino sugar GlcNAc and
the sialic acid, N-acetylneuraminate, are widely incorporated
into glycoconjugate mucins and cell surfaces (1). These carbo-
hydrates can be scavenged from host glycoconjugates and
metabolized by mucosal pathogens, such as Staphylococcus
aureus (2), as a nutrient source (3–6).
Just as the phosphorylation of glucose in the early phase of
glycolysis (sometimes referred to as the “energy investment
phase”) drives otherwise unfavorable reactions in the payoff
phase as glucose is catabolized, in the bacterial sialic acid
import and degradation pathway (Fig. 1A), phosphorylation
serves to prime the amino sugar for downstream catabolism
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through glycolysis, or anabolism by synthetic pathways, includ-
ing cell wall synthesis (10, 12). Here, we focus on the second
step of the catabolic pathway: the phosphorylation ofN-acetyl-
mannosamine catalyzed by N-acetylmannosamine kinase
(henceforth abbreviated to NanK).
In bacteria, enzymes from two distantly related protein fam-
ilies carry out ATP-driven sugar phosphorylation (13): the glu-
cokinase family (14) and the Repressor, ORF, Kinase (ROK)3
family (15). Both families have the RNase H-like protein-fold, a
sugar substrate-induced conformational change, ATP-binding
DXGXT and GTGXGmotifs, and a sugar-binding EXGHmotif
(13, 15). The sugar substrate-binding site is also somewhat con-
served, with ligand–bound crystal structures showing five con-
served sugar-binding residues (Fig. 1B) (13). The key difference
between the families is that ROK proteins have a Zn-binding
motif (CXCGXXGCX(E/D)) that buttresses the EXGH motif
histidine, placing it in the correct position for substrate binding
(Fig. 1C). In contrast, the glucokinase family lack the Zn-bind-
ingmotif and instead have an additional-helix to structure the
region (16).
We conducted a sequence alignment of NanK enzymes from
bacteria, which are expected to be part of the ROK family (13).
Curiously, we found that the majority of Gram-positive bacte-
rial NanK sequences lack the Zn-binding motif and the -helix
used in the glucokinase family (Fig. S1). This is best shown in an
alignment of representative NanK sequences (Fig. S2), which
reveals that the cysteine residues usually involved in forming
3 The abbreviations used are: ROK, repressor, ORF, kinase; PDB, Protein Data
Bank; RMSD, root mean square deviation.
Figure 1. A, a schematic of sugar flow through the bacterial sialic acid catabolism pathway. NanK catalyzes the conversion of N-acetylmannosamine and ATP
to form N-acetylmanosamine-6-phosphate and ADP. This proposed pathway is based on experimental evidence from S. aureus (4), Bacillus subtilis and
Escherichia coli (55), as well as from KEGG genome data (56). For clarity, substrate and enzyme names are abbreviated. Enzymes used were: sialic acid
transporter (6 –8), N-acetylneuraminate lyase (57, 58), NanK, N-acetylmannosamine-6-phosphate 2-epimerase (59, 60), GlcNAc-6-phosphate deacetylase, and
glucosamine-6-phosphate deaminase (12). Substrates used were: N-acetylneuraminate, N-acetylmannosamine, N-acetylmannosamine-6-phosphate,
GlcNAc-6-phosphate, glucosamine-6-phosphate, and fructose-6-phosphate. B, structures of sugar-bound ROK and non-ROK sugar kinases have a highly-
conserved sugar-binding site. Glucokinase family E. coli glucokinase is shown in pink (PDB 1SZ2), ROK S. griseus glucokinase in green (PDB 3VGL), ROK B. subtilis
fructokinase in cyan (PDB 3LM9), and ROK human bi-functional UDP-GlcNAc 2-epimerase/NanK in red (PDB 2YHY). C, this image shows the orientation of the
EXGH motif (green) and ROK Zn-binding motif (red) relative to the sugar-binding site (PDB 3VGL).
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the Zn-binding motif are absent in sequences of Gram-positive
S. aureus and Streptococcus mitis species, and the histidine of
the EXGH motif is substituted with a tyrosine (EXGY) (17).
This is surprising, as Zn-binding is required for activity in ROK
proteins (15, 18), is present throughout Gram-negative NanK
isozymes (13, 19), and the Zn-binding motif differentiates the
ROK family from the glucokinase family (15).
Given that many Gram-positive NanK enzymes have been
traditionally annotated as ROK enzymes, but are missing the
essential Zn-bindingmotif, and instead have a tyrosine in place
of histidine from the sugar-binding EXGH motif, we studied
how Gram-positive S. aureus NanK (SaNanK) functions with-
out these canonical features. Here we report the first functional
and structural study of a Gram-positive NanK. We discovered
that the enzyme is active without Zn-binding, has a unique
structured arginine-stack in a position equivalent to the ROK
Zn-binding motif, or glucokinase family -helix, and that the
tyrosine in the EXGY motif provides specificity for the
N-acetylmannosamine substrate.
Results and discussion
SaNanK N-acetylmannosamine kinase catalytic function
We first verified whether SaNanK was a N-acetylman-
nosamine kinase using an established assay for measuring
initial rate data (19). The enzyme is active with N-acetylman-
nosamine and ATP. Initial rate data, where both acetylman-
nosamine andATP concentrations are varied, are best fitted with
the ternary complex kinetic model (Fig. 2A), with an R2  0.999
(see “Experimentalprocedures” foradiscussiononhowthismodel
was chosen). This gives the following kinetic parameters:
Km
N-acetylmannosamine
 0.30 mM, Km
ATP
 0.73 mM, and kcat 
262.6 s1 (Vmax  497molmin
1mg1) (Table 1). The kcat/Km
forN-acetylmannosamine is 870mM1 s1, which is on the same
order as the only other bona fide bacterial NanK enzyme charac-
terized (from Escherichia coli) (19), and other ROK kinases (19–
23). Thus, SaNanK is catalytically active and kinetically compara-
ble with other ROK kinases, despite missing conserved and
defining active site motifs thought to be important for function.
Three ROK Streptomyces glucokinases have been reported
to have a compulsory-orderedmechanism,where glucose binds
the active site beforeATP (16, 24).When the initial rate data are
presented as double-reciprocal plots the pattern provides infor-
mation on whether the ternary complex kinetic mechanism is
of the random- or compulsory-ordered type with respect to
substrate binding (25). The plots for SaNanK are consistent
with a random-ordered ternary complex for catalysis (Fig. S5).
These results demonstrate that SaNanK binds substrate differ-
ently than Streptomyces ROK glucokinases, which presumably
have a structural feature that prevents ATP from binding first.
Glucose kinase activity is thought to be the ancestral function
for the ROK family (13). Glucose differs from N-acetylman-
nosamine in that a equatorial (R)-hydroxyl at the C2 position is
substitutedwith an axial (S)-N-acetyl group. Toprobe substrate
specificity for the C2 position, we compared the catalytic func-
Figure 2. Kinetic assays with N-acetylmannosamine kinase. A, rate versus N-acetylmannosamine and ATP concentration fitted with the ternary complex
kinetic model: Km (N-acetylmannosamine)  0.30  0.01 mM, Km
(ATP)
 0.7 mM, Vmax  497  7 mol/min/mg, kcat  263  3 s
1. B, rate versus GlcNAc
concentration fitted to the Michaelis-Menten model: Km
app
 0.26 mM, Vmax  114 mol/min/mg, kcat
app
 23.4  0.2 s1. C, rate versus glucose concentration
fitted to the Michaelis-Menten model: Km  15  1 mM, Vmax  44.4  0.3 mol/min/mg, kcat  60  1 s
1.
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tion with N-acetylmannosamine against glucose and GlcNAc,
which are C2 substrate analogs. The apparent Km (Km
app) of
GlcNAc (260 M) is comparable with N-acetylmannosamine
(300 M) (Fig. 2B). However, the kcat (23 s
1) is 11-fold lower.
The Km
app for glucose (15 mM, Fig. 2C) is 60-fold higher than the
N-acetyl substrates, highlighting that the C2 N-acetyl group is
important for binding to the enzyme. In ROK glucokinases, the
C2position is boundby the EXGHmotif histidine (13), which in
SaNanK is changed to tyrosine and represents an uncharacter-
ized change within the ROK protein family. This result demon-
strates that the N-acetyl substrate group is important for sub-
strate binding and consequently the residues of the enzyme that
coordinate the N-acetyl are important for substrate specificity.
Overall, we demonstrate that SaNanK is a bona fideN-acetyl-
mannosamine kinase with catalytic constants comparable with
canonical ROK kinases that have the EXGH and Zn-binding
motif. We show that SaNanK catalysis has a random-ordered
ternary mechanism, in contrast to Streptomyces glucokinases,
which bind glucose first. The difference in kinetic mechanism
suggests that SaNanK has novel structural features, which may
be related to the altered protein sequence.We also demonstrate
that the C2 N-acetyl group of the substrate is important for
substrate binding.
Structure of SaNanK
To investigate the structural implications of the missing
canonical ROK motifs and the altered kinetic mechanism rela-
tive to other glucokinases, we solved the crystal and solution
structure of SaNanK in the ligand–free, N-acetylman-
nosamine–bound, and GlcNAc–bound forms. The ligand-free
structure was solved to 2.33 Å resolution. Because we were
unable to solve the structure using molecular replacement, sel-
enomethionine-substituted enzyme was crystallized as previ-
ously described (17) and initial phases were determined using
SHELX (26). The asymmetric unit contains four NanK mono-
merswhere chainsA,B, andCare complete, but chainDhas three
regions where electron density is ambiguous and cannot be
modeled (Gln-28–Pro-33, Pro-82–Pro-85, Asn-142–Gln-144).
N-Acetylmannosamine–bound and GlcNAc–bound SaNanK
structures were each solved at 2.20 Å resolution, using the ligand-
free structure for molecular replacement. Electron density was
present and distinguishable for all residues, except Met-1. The
data collection and refinement statistics are given in Table 2.
The SaNanK monomer
The SaNanKmonomer features two domains, anN-terminal
/ domain (Fig. 3A, red) and a larger  domain (Fig. 3A,
pink) that together form the RNase H-like–fold. The domains
are orientated such that themonomer resembles an open clam,
with the two separated domains being joined at a single hinge
region (Fig. 3A, green). The active site is situated between the
two “half-shell” domains, where residues from both domains
are used to bind substrate and support catalysis. The structure
is consistent with canonical ROK kinases, with the secondary
structure regions matching E. coli NanK (Fig. S6) and compar-
ison with TM-align (27) provides a structure match score of
84.4 and 86.6%withE. coliNanK (PDB2AA4) and Streptomyces
griseus glucokinase (PDB 3VGK), respectively.
The active sites of ROK kinases are generally well-conserved
(13). Mapping the sequence alignment to the structure demon-
strates that it is themost highly-conserved area of SaNanK (Fig.
3B). However, from our sequence analysis, there is a major
change to the region with the absence of a Zn-binding motif,
which in canonical ROK partially encloses the active site from
the sugar side (PDB 3VGL). In SaNanK, the region equivalent
to the Zn-bindingmotif is shorter (13 versus 20 residues) and is
folded away from the active site area, interacting with residues
of the large  domain.
SaNanK is a dimer, consistent with other NanK enzymes
To determine the relevant oligomeric state in solution, sedi-
mentation velocity analytical ultracentrifugation and small
angle X-ray scattering experiments were conducted. Both
experiments demonstrate that SaNanK is a dimer (across the
concentration range tested).
Sedimentation velocity data were fit with the c(s) and c(M)
models using SEDFIT (28), which give a single peak corre-
sponding to 3.95 S and 62 kDa (Fig. 4A); thus, ligand-free
SaNanK is a dimer in solution given a monomeric mass of 31.7
kDa calculated from the sequence. A single peak is evident at
each concentration, suggesting that the equilibrium constant
for dimer dissociation (KD
2-1) is very low. Small angle X-ray scat-
tering data are also consistent with a dimer. The theoretical
scatter for the ligand-free SaNanK canonical dimer formed in
the crystal structure (generated by CRYSOL from the ATSAS
package (29)) fitted closely to the scattering data (2  1.7) (Fig.
4B). We also tested a possible dimer formed by a secondary
interface in the asymmetric unit (as defined by PDBe PISA (30),
and the full asymmetric unit of the ligand-free structure (two
dimers) (Fig. S7), both of which fitted poorly to the scattering
data. The dimeric configuration is consistent with other NanK
crystal structures (19, 31, 32) and MALDI-TOF MS analysis of
(ROK) glucokinase from Bacillus subtilis (15).
Fromthecrystal structure, thedimericconfigurationorients the
active sites facing outward on opposite sides of the assembly,
whereas the hinge regions are near the center (Fig. 4C). Residues
Table 1
Kinetic parameters for wildtype SaNanK
The Vmax, kcat, and Km were calculated in GraphPad Prism. The error is the mean  S.E. of the fit. N-Acetylmannosamine parameters were produced from global fits by
varying ATP.
N-Acetylmannosamine Glucosea GlcNAca
Vmax (mol/min/mg) 497  7 114  3 44.4  0.3
kcat (s
1) 263  3 60  1 23.4  0.2
Km (mM) 0.30  0.01 15  1 0.260  0.005
kcat/Km (s
1/mM) 871  34 4.0  0.3 90  3
ATP Km (mM) 0.73  0.02
a Glucose and GlcNAc are apparent parameters, using a saturating ATP concentration.
N-Acetylmannosamine kinase from S. aureus












































from the large domain form the dimerization interface. This
configuration is consistentwithE. coli,Fusobacteriumnucleatum,
and Homo sapiens (19, 31, 32). PDBe PISA analysis indicates that
theSaNanK interfacehas a surface areaof 1533.8Å2, featuring five
salt bridges and 18 hydrogen bonds. The residues identified by
PDBe PISA contribute to three positive and three negatively
charged regions that charge complement the opposingmonomer
(Fig. 4D).
In summary, we demonstrate that SaNanK is a dimer. The
dimeric interface consists of three complementary positive and
negative patches on the surface of large  domain.
Substrate-induced changes in conformation
A conformational change upon sugar binding, whereby the
lobes of the enzyme close over the substrate, has been demon-
strated in both the ROK and glucokinase families (14, 16, 31).
Whether SaNanK undergoes a similar conformational change
was determined by comparing the sugar substrate–bound and
ligand-free X-ray crystal structures. In the N-acetylman-
nosamine–bound SaNanK structure the two domains are
shifted 7 Å inwards and close around the substrate, like the
shells of a clam enclosing a pearl (Fig. 5A). As a dimer, the
Table 2
Data collection and refinement statistics
Ligand-free N-Acetylmannosamine-bound GlcNAc-bound
PDB 6Q26 6Q27 6Q28
Wavelength 0.9724 0.954 0.954
Resolution range 48.736–2.328 (2.412–2.328) 44.556–2.200 (2.279 2.200) 47.88–2.2 (2.279–2.200)
Space group C 2 2 21 P 21 P 21
Unit cell 116.7, 135.2, 175.3 47.2, 101.4, 133.2; 90.15 47.9, 102.0, 133.3; 90.14
Total reflections 867,330 (83,021) 124,343 (11,758) 255,819 (25,619)
Unique reflections 59,453 (5,864) 63,756 (6,331) 64,898 (6,477)
Multiplicity 14.6 (14.2) 2.0 (1.9) 3.9 (4.0)
Completeness (%) 99.9 (99.4) 99.9 (99.9) 99.8 (99.5)
Mean I/sigma(I) 20.0 (1.9) 4.9 (1.0) 5.3 (0.9)
Wilson B-factor 30.98 43.34 30.46
Rmerge 0.237 (1.557) 0.083 (0.523) 0.315 (0.692)
Rmeas 0.245 (1.615) 0.117 (0.740) 0.368 (0.804)
Rpim 0.064 (0.424) 0.083 (0.523) 0.187 (0.405)
CC1/2 0.994 (0.671) 0.988 (0.704) 0.881 (0.701)
Reflections used in refinement 59,447 (5864) 63,746 (6330) 64,886 (6477)
Reflections used for R-free 6,036 (622) 6,340 (603) 3,202 (315)
Rwork 0.1973 (0.2711) 0.1940 (0.3098) 0.2198 (0.3312)
Rfree 0.2400 (0.3284) 0.2324 (0.3362) 0.2400 (0.3480)
Number of non-hydrogen atoms 9,103 8,989 9,230
Macromolecules 8,808 8,840 8,896
Ligands NAa 60 60
Solvent 295 89 274
Protein residues 1,131 1,140 1,144
RMSD (bonds) 0.009 0.009 0.016
RMSD (angles) 1.30 1.27 1.77
Ramachandran favored, allowed, outliers (%) 98.3, 1.7, 0 98.1, 1.9, 0 98.2, 1.7, 0.1
Rotamer outliers (%) 0 0.64 0.53
Average B-factor (Å2) 37.1 51.9 38.3
Macromolecules 37.3 51.8 37.9
Ligands NA 69.8 55.1
Solvent 32.3 55.6 48.3
Number of TLS groups 15 16 24
Anomalous completeness (%) 99.9 (98.3)
Anomalous multiplicity 7.6 (7.2)
a NA, not applicable.
Figure 3. Monomeric structure of SaNanK. A, the monomer has two domains: an N-terminal / domain (red) and a larger  domain (pink). The hinge
region (green) joins the two domains and involves two -helices shared between the domains. The active site is opposite the hinge region between the two
domains. B, the active site residues of ROK kinases are highly conserved. Sequence alignment of ROK kinases listed in Table S1. Active sites residues are highly
conserved (maroon) and residues elsewhere are poorly conserved (cyan). Image produced using ConSurf (62) and UCSF Chimera software (63).
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movement occurs mainly in the N-terminal / domain, piv-
oting at the hinge region, as the large  domain is set by the
dimeric interface. Overall, the conformational change of
SaNanK is consistent with other ROK kinases (14, 16, 31).
The purpose of a conformational change is hypothesized to
ensure that ATP hydrolysis occurs only when sugar substrate is
present, providing efficient catalysis (31). To investigate, the
catalytic residues identified from the sequence alignment (Fig.
S2) were compared between ligand–free and N-acetylman-
nosamine–bound structures. In the catalytic mechanism for
sugar kinases, ATP is primed for nucleophilic attack at the
-phosphate by electron withdrawal through the -phosphate,
which then undergoes nucleophilic attack by the sugar (31). For
SaNanK, electron withdrawal likely occurs via Asp-7 binding
Mg2 associated with the ATP -phosphate, given its proxim-
ity, whereas Thr-11 and Thr-134 hydrogen bondwith the other
side of the -phosphate group. Alignment ofMgADP from the
human NanK structure demonstrates that when N-acetylman-
nosamine is bound, Thr-134 is shifted toward the expected
-phosphate position (Fig. 5B, pink) and both Asp-7 and Thr-
11, which are part of the N-terminal / domain, make a large
shift toward the ATP position (Fig. 5B, red). Importantly, this
shows that Asp-7, Thr-11, and Thr-134 are in position to pro-
vide electron withdrawal in theN-acetylmannosamine–bound
structure and not the ligand-free structure. In short, this is
consistent with a conformational change that ensures ATP is
only hydrolyzed in the presence of substrate (discussed in
Ref. 31).
As conformational change is important for catalysis in
ROK kinases (discussed above), the GlcNAc and N-acetyl-
mannosamine–bound structures were compared to ration-
Figure 4. Oligomeric state of SaNanK. A, sedimentation velocity experiments with SaNanK at three concentrations (0.3, 0.6, and 0.9 mg ml1; 9.5, 18.9, and
27.4 M). The fit of the model to the data (Fig. S4) provides a molecular mass of 62 kDa, corresponding to a dimer (monomer mass is 31.7 kDa). B, small-angle
X-ray scattering of SaNanK (6 mg ml1). Ligand-free SaNanK experimental data (red circles) corresponds with theoretical scatter (red line), with a reduced 2 of
1.7 versus 4.9, compared with the N-acetylmannosamine crystal structure scatter (blue line). C, structure of the SaNanK dimer, which is formed through residues
of the larger  domain (pink), with the hinge region (green), and large N-terminal / domain (red) free in solution. D, the dimeric interface of SaNanK. The
electrostatic surface (generated using PyMOL) shows three opposing negative and positive areas, which pair when the dimer interface forms. Residues
involved with dimerization were determined using PDBe PISA and were mapped onto the surface of SaNanK.
N-Acetylmannosamine kinase from S. aureus












































alize the lower catalytic rates with GlcNAc. The structure
of GlcNAc–bound SaNanK is similar to the N-acetyl-
mannosamine–bound structure but appears to be slightly
more open (Fig. S8), with an average RMSD for the four
chains of 0.42 Å using 262–265 of the 285 residues (PyMOL).
This alters the distances between catalytic residues Thr-11
and Thr-134, which provide electron stabilization to the
-phosphate of ATP and provides a possible explanation for
lower catalytic rates with GlcNAc.
We then examined whether conformational change
explains why the enzyme operates via an ordered or random
kinetic mechanism. To do this we compared the ligand-free
and sugar–bound structures of SaNanK, which has a ran-
dom ordered kinetic mechanism, with S. griseus glucokinase
(PDB 3VGK and 3VGM), which has a compulsory-ordered
kinetic mechanism, where glucose binds first and then ATP
binds (16). Both SaNanK and S. griseus glucokinase undergo
a similar overall conformational shift, pivoting at the hinge
region in response to sugar-binding and the ATP pocket is
essentially unchanged (Fig. S9). Therefore, conformational
change does not seem to explain why some ROK kinases have
a random kinetic mechanism, whereas others have a com-
pulsory-ordered kinetic mechanism.
To test whether the conformational change seen in the crys-
tal structure also occurs in solution, small angle X-ray scatter-
ing was used. The scattering profile with and withoutN-acetyl-
mannosamine were individually compared with the theoretical
scatter of the crystal structures with and withoutN-acetylman-
nosamine using CRYSOL (33). The scattering data from the
ligand-free SaNanK sample closely matches the ligand-free
SaNanK crystal structure, but not the N-acetylmannosamine–
bound crystal structure, (reduced 2 of 1.7 versus 4.9) (Fig. 4B).
In contrast, the scattering data for SaNanK in the pre-
sence of N-acetylmannosamine (5 mM) closely matches the
N-acetylmannosamine–bound crystal structure, but not the
ligand-free SaNanK crystal structure (reduced 2 of 1.9 versus
9.9) (Fig. 5C). This demonstrates that the crystal structures
match the solution structures and the enzyme closes around
N-acetylmannosamine. The condensing of the N-acetylman-
nosamine solution structure is further supported by a smaller
radius of gyration calculated from the overall scattering inten-
sity (Rg  26.9 versus 27.5 Å) (Fig. 5D).
To summarize, SaNanK undergoes an N-acetylman-
nosamine–induced conformational change adopting a closed
conformation. This ensures ATP hydrolysis only occurs in the
presence of sugar substrate. In support, the catalytic residues
(Asp-7, Thr-11, and Thr-134) that withdraw electrons from
the -phosphate group are only in an active configuration in
the closed conformation. Adherence to the closed and open
conformations, with and without ligand, respectively, is
demonstrated in solution by small angle X-ray scattering.
Figure 5. Conformational change in SaNanK. A, comparison of ligand–free and N-acetylmannosamine– bound structures demonstrates that the N-terminal
/ domain (red to white) closes around N-acetylmannosamine, pivoting at the hinge region (green). B, expected catalytic residues of SaNanK. The N-terminal
/ domain moves bringing Asp-7 and Thr-11 toward the active site, which in conjunction with Thr-134 prime ATP for nucleophilic attack. The expected
position of ATP was indicated by aligning the human NanK structure with N-acetylmannosamine and MgADP bound (PDB 2YHY). Asp-108 binds and depro-
tonates the C6 hydroxyl of N-acetylmannosamine, increasing nucleophilicity of the sugar. C, small-angle X-ray scattering of SaNanK (6 mg ml1) and N-acetyl-
mannosamine (5 mM). Experimental data (blue circles) corresponds with theoretical scatter of the N-acetylmannosamine-bound crystal structure (blue line),
with a reduced 2 of 1.9 versus 9.9, compared with the ligand-free crystal structure scatter (red line). D, radius of gyration calculated from intensity during small
angle X-ray scattering. The radius of gyration was calculated to be condensed when N-acetylmannosamine is bound (26.9 versus 27.5 Å), which is consistent
with the inward shift represented by the crystal structure.
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The SaNanK active site uses tyrosine to bind the substrate C2
position
Five sugar substrate-binding residues are reported to bewell-
conserved in ROK kinases (13) and conservation was investi-
gated in SaNanK. Four of the five residues are conserved,
including Asn-107, Asp-108, Glu-157, and Glu-172, whereas
Tyr-160 is a nonconservative change and replaces the histidine
in the canonical EXGHmotif (discussed later). TheC1hydroxyl
of N-acetylmannosamine is bound by Glu-172, and Glu-157
primarily binds C3, but also binds the C2 position N-acetyl
moiety. Both residues are part of the larger  domain (Fig.
6A, magenta). Asn-107 binds the C4 hydroxyl and Asp-108
binds C6 (Fig. 6A). These residues border the N-terminal /
domain and the hinge region, where the conserved substrate
binding translates to the conformation change between the
ligand–free and N-acetylmannosamine–bound structures. In
addition to substrate binding, the conservedAsp-108 that binds
theC6 position is also expected to feature in the catalyticmech-
anism by deprotonating the hydroxyl and increasing nucleo-
philicity (34). Consistent with the mechanism, Asp-108 is pre-
dicted to be deprotonated in the ligand–free structure (pKa 
6.03), but protonated in the N-acetylmannosamine–bound
structure (pKa  9.14), using PDB2PQR (35) at pH 7.
The structural role of Tyr-160 in the EXGYmotif of SaNanK
is a nonconservative substitution of the Zn-binding histidine in
the EXGH motif seen in canonical ROK kinases. Indeed, tyro-
sine at this position is conserved in other Gram-positive NanK
lacking theZn-bindingmotif (Fig. S1). The hydroxyl of SaNanK
Tyr-160 binds the C2N-acetyl group ofN-acetylmannosamine
(Fig. 6A). This is analogous to ROK glucokinase, where the
equivalent EXGHmotif histidine binds the C2 hydroxyl of glu-
cose (16). However, glucose is much smaller and the EXGH
motif histidine also bindsZn. Zn-bindingNanKenzymes utilize
the EXGH motif histidine to bind the C1 hydroxyl and the
larger N-acetyl substrate is bound from residues on the other
side of the active site (31). A comparison of substrate binding is
presented in Fig. 6B. In contrast to histidine found in the Zn-
binding structures, SaNanK Tyr-160 tilts away from the active
site, increasing the size of the active site, and hydrogen bonds
with the N-acetyl group. Interestingly, N-acetylmannosamine
binds in a “boat” conformation and the N-acetyl group is in a
pseudo-equatorial position (Fig. 6B, Figs. S10 and S11). It is
unknown whether these observations are typical for NanK
without the Zn-binding motif, although our sequence align-
ment suggests that tyrosine is consistently present at the
position.
Our earlier kinetic analysis revealed that the C2 N-acetyl
group is important for binding, with the Km of both N-acetyl-
mannosamine and GlcNAc (0.30 and 0.26 mM, respectively)
being much lower than glucose (15 mM), which only differs at
Figure 6. Involvement of SaNanK Tyr-160 in substrate association. A, N-acetylmannosamine-bound SaNanK. Gly-68, Asn-107, Asp-108, Glu-157, and
Glu-172 bind the hydroxyl groups of N-acetylmannosamine and Gly-81, Glu-157, and Tyr-160 bind the C2 N-acetyl group. B, comparison of sugar substrate
binding in SaNanK (blue), S. griseus glucokinase (green), and human NanK (pink). In SaNanK, the EXGH motif histidine is replaced by a tyrosine (Tyr-160), which
binds the larger N-acetylated substrate by tilting backward from the active site and having greater length than histidine. In human NanK, the EXGH motif
histidine bind the C1 hydroxyl and the axial N-acetyl group is bound by other nonconserved residues. C, GlcNAc bound SaNanK. The N-acetyl carbonyl group
is not able to hydrogen bond with Tyr-160. D, Tyr-160 provides substrate specificity toward N-acetylmannosamine, over GlcNAc. When tested with N-acetyl-
mannosamine (blue, left axis), WT SaNanK has more substrate specificity (870 mM1 s1) than Y160F-substituted enzyme (170 mM1 s1), which are absent the
Tyr-160 hydroxyl. When tested with GlcNAc (orange, right axis), WT SaNanK has less substrate specificity (90 mM1 s1) than Y160F-substituted enzyme (390
mM1 s1), demonstrating that Tyr-160 provides substrate specificity against GlcNAc.
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the C2 position. To investigate further, the GlcNAc–bound
andN-acetylmannosamine–bound structures were compared.
Both substrates are bound at the C1, C3, C4, and C6 hydroxyls
by Glu-172, Glu-157, Gln-107, and Asp-108, respectively (Fig.
6, A and C). These positions are conserved with S. griseus glu-
cokinase and glucose is expected to bind with SaNanK in a
similar manner. At the C2 position, the N-acetyl groups are
both in an equatorial position, despite being enantiomers.
N-Acetylmannosamine adopts a boat conformation with the
carbonyl pointing “down” and theN-acetyl is positioned to bind
three residues, Gly-81 to the carbonyl, Glu-157 to both the car-
bonyl and amine, andTyr-160 to carbonyl (Fig. 6A). In contrast,
GlcNAc adopts a “chair” conformation with carbonyl pointing
“up” and the N-acetyl group is positioned to bind two residues
only, Gly-81 to the carbonyl andGlu-157 to the amine (Fig. 6C).
The comparison reveals that the SaNanK active site is structur-
ally optimized to bind N-acetylmannosamine, over GlcNAc
and glucose.
Next, we tested the role of the Tyr-160 hydroxyl in substrate
specificity by producing substituted enzyme SaNanK-Y160F
and comparing its kinetic profile (Table 3 and Fig. 6D). For
N-acetylmannosamine, the specificity constant for the WT
(kcat/Km  870 mM
1 s1) is greater than the Y160F-substi-
tuted enzyme (kcat/Km  170 mM
1 s1). This is consistent
with the participation of the Tyr-160 hydroxyl in substrate
binding for WT SaNanK. For GlcNAc, the specificity constant
for the WT (kcat/Km  90 mM
1 s1) is lower than the Y160F-
substituted enzyme (kcat/Km  390 mM
1 s1). This suggests
that the Tyr-160 hydroxyl may have a role in perturbing
GlcNAc binding. In support of this, Tyr-160 is displaced by 1Å,
compared with the ligand–free and N-acetylmannosamine–
bound structures, indicating that the residue sterically hinders
GlcNAc binding. Together, the results demonstrate that the
Tyr-160 hydroxyl is important for specificity toward the path-
way substrate, with a 5:1 preference for N-acetylmannosamine
with tyrosine, compared with a 2:1 preference for GlcNAc
when replaced with phenylalanine. Controls with Y160A-sub-
stituted enzyme (Table 3) were similar to Y160F and further
support that the tyrosine hydroxyl is important for N-acetyl-
mannosamine specificity.
Without the Zn-bound EXGH motif histidine, SaNanK
binds the N-acetyl group of N-acetylmannosamine with tyro-
sine, which is generally conserved inGram-positiveNanKwith-
out the Zn-bindingmotif. This is different to Zn-binding NanK
enzymes, which bind the N-acetyl group using residues on the
other side of the active site (31). The tyrosine residue is impor-
tant for substrate recognition and when replaced with pheny-
lalanine, substrate preference shifts to GlcNAc.
The ROK Zn-binding motif is replaced by a stabilizing arginine
stack
SaNanK does not have the highly-conserved ROK Zn-bind-
ing motif, however, the significance of this is unknown as the
purpose of the motif is not well-understood (13). To identify
structural differences, SaNanK was compared with a ROK and
a non-ROK sugar kinase. In ROK S. griseus glucokinase, the
Zn-binding region encompasses 20 residues, starting from the
Zn-binding EXGH motif His-157 to the end of the motif,
CXCGXXGCX(E/D) (residues 167–176, PDB 3VGK). The
EXGH motif histidine and the Zn-motif Glu/Asp bind to the
sugar, with the central residues forming a loop that wraps
aroundZn (Fig. 1C) enclosing the active site (Fig. 7A, green). For
SaNanK ROK without the Zn-motif, the equivalent region
between the sugar-binding Tyr-160 and Glu-172 (13 residues)
forms a loop that associates with the large  domain and
does not occlude the sugar active site (Fig. 7A, red). In non-ROK
E. coli glucokinase, the equivalent region is 28 residues long
(His-160–Glu-187) and features highly charged residues as
part of the dimerization interface (14). This does not occlude
the sugar active site (Fig. 7A, yellow) in a position similar to the
SaNanK region. The observations suggest that the absence of
Zn-binding corresponds with an open sugar active site and the
presence of Zn-binding corresponds with a closed active site.
The absence or presence of the Zn-motif may determine the
order of substrate binding.We propose that SaNanK has a ran-
dom-order kinetic model because the absence of the Zn-motif
provides a secondary substrate entry point, whereas in the com-
pulsory-order S. griseus glucokinase there is a narrow active site
with a just a single entry and glucose must access the pocket at
the bottom before ATP binds. Kinetics assays demonstrate that
SaNanK uses a random-order ternary complex for catalysis,
whereas canonical ROK S. griseus glucokinase is characterized
as a compulsory-ordered complex that requires glucose to bind
before ATP (16). Initially, conformational change was investi-
gated as a method of conferring order (discussed above), but
comparisons of the enzyme structures failed to identify a differ-
entiating feature in ATP-binding site and it is difficult to attrib-
ute the difference in mechanism to conformational change.
Compulsory-ordered S. griseus glucokinase has a narrow active
site with a single opening near the ATP-binding pocket (Fig.
7A). Glucose binds at the bottom of the active site and ATP
binding would obstruct glucose binding, thus providing an
explanation of why glucose must bind before ATP. In contrast,
SaNanK has a secondary opening near the active site that
N-acetylmannosamine can access irrespective of ATP binding
providing for a random-ordered kinetic mechanism.
Table 3
Kinetic parameters for SaNanK substituted at Tyr-160
Without the Tyr-160 hydroxyl group, SaNanK-Y160F and SaNanK have a higher enzyme specificity (kcat/Km) with GlcNAc than for N-acetylmannosamine, the pathway
substrate. The Vmax, kcat, and Km were calculated in GraphPad Prism. The error is the mean  S.E. of the fit. Values are apparent parameters, using saturating ATP
concentration.
N-Acetylmannosamine GlcNAc
SaNanK-Y160F SaNanK-Y160A SaNanK-Y160F SaNanK-Y160A
Vmax (mol/min/mg) 408  5 422  8 36.1  0.3 33.6  0.3
kcat (s
1) 216  3 223  4 19.1  0.2 17.8  0.2
Km (mM) 1.27  0.1 1.34  0.1 0.049  0.002 0.057  0.003
kcat/Km (s
1/mM) 171  13 167  13 390  16 310  16
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ROK Zn-binding has been demonstrated elsewhere to be
necessary for activity (15, 18), and Zn coordination is hypothe-
sized to organize three nearby active site residues (16). The
organization of equivalent residues (Glu-157, Tyr-160, and
Glu-172) were examined in SaNanK to investigate why the
enzyme is active without Zn-binding. Glu-157, Tyr-160, and
Glu-172 are well-organized in the ligand-free structure with
lower B-factors (17.5, 13.8, and 18.8) than the model average
(37.7), despite little secondary structure organization in the
region. The nearby region, equivalent to the ROK Zn-binding
region, was examined for potential stabilizing features. Inter-
estingly, the region features two stacked arginine residues (Arg-
164 and Arg-174), ionically coordinated by three negatively
charged residues (Glu-167, Asp-219, and Glu-222), with two of
the negative residues belonging to a large -helix that anchors
the arginine stack (Fig. 7B). Potentially, this five-coordinate fea-
ture stabilizes the region and organizes the active site residues,
serving the hypothesized role of four-coordinate Zn-binding in
canonical ROK.
Re-examination of Gram-positive NanK sequence align-
ments reveals that the arginine stacking residues are novel
within the Staphylococcus genus and Arg-164, which is coordi-
nated by four other residues, is not conserved elsewhere (Fig.
S12). Arg-164 was substituted with alanine and we test the
effect of this change on thermal stability to test for structural
stabilization, and kinetic assays to test whether the residue is
important for active site organization (a hypothesized role of
the equivalent Zn-binding region (16)). SaNanK-R164A was
not recoverable in the soluble fraction and attempts to improve
solubility by altering the expression temperature and length
were unsuccessful. This suggests the enzyme is potentially
unstable without the positive charge or hydrophobic stacking
supplied by arginine. However, SaNanK-R164K was success-
fully purified. Thermal stability analysis reveals that SaNanK-
R164K has an average Tm of 35.4 °C, which is 4.1 °C lower than
SaNanK (Fig. 7C), and in conjunction with insolubility of
SaNanK-R164A, this indicates that arginine interaction is
important for stabilization. Kinetic assays show that the substi-
tuted enzyme is catalytically compromised (Vmax  6.1  0.3
mol/min/mg, kcat  3.2 0.2 s
1,Km  0.26 0.01mM) with
approximately a 100-fold decrease in activity compared with
WT (kcat  262.6 s
1). This is consistent with arginine stacking
contributing to organize the nearby active site residues. This is
a hypothesized role of the ROK Zn-binding region, which is
equivalently positioned to the SaNanK arginine stack, and we
propose that both coordinating features provide stabilization
and organization.
Figure 7. Arginine stacking feature in the region equivalent to the ROK Zn-binding motif. A, comparison of region equivalent to the ROK Zn-binding
motif. In non-Zn– binding ligand-free SaNanK (red) the region is positioned away from the sugar active site. In Zn-binding ROK S. griseus glucokinase (PDB
3VGK) (green) the region partially covers the sugar active site. Glucokinase family E. coli glucokinase (PDB 1Q18) (yellow) has a larger region featuring an -helix
and is positioned away from the sugar active site. N-Acetylmannosamine and ATP substrates were aligned from N-acetylmannosamine– bound SaNanK and
ROK kinase (PDB 3VGL). B, in the region equivalent to the Zn-binding motif (blue), SaNanK features a -stacking arginine pair, which are coordinated by three
negative residues. Two of the negative residues are part of a large -helix (pink) stabilizing the protein loop and positioning it away from the active site. Stable
positioning of the region is important as it features three active site residues (Glu-157, Tyr-160, and Glu-172), which bind to N-acetylmannosamine (black). C,
differential scanning fluorimetry with SaNanK (solid line) and SaNanK-R164K (dashed line). SaNanK-R164K has lower thermal stability with the average melting
temperature of the two domains is 4.1 °C lower than WT.
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The absence of the Zn-binding motif increases the poten-
tial of SaNanK as a drug target. Elsewhere, it has been dem-
onstrated that the bacterial sialic acid catabolic pathway is a
viable target to lower infectivity and increase antibiotic effi-
cacy (1, 3, 4, 9, 10). Targeting the pathway is only useful if
toxic interaction with host sialic pathway enzymes can be
avoided. The NanK component of human bifunctional
UDP-GlcNAc 2-epimerase/N-acetylmannosamine kinase is
a ROK family protein but, unlike SaNanK, it retains the
canonical Zn-bindingmotif (31). The structure of the human
enzyme (PDB 2YHY) shows that bound N-acetylman-
nosamine is enclosed by the Zn-binding motif and the
N-acetyl group associates in the axial position. Whereas, our
characterization demonstrates that SaNanK is open at the
N-acetylmannosamine end of the active site (Fig. 7A). There-
fore, we propose that synthesized glucose or mannose C2 (or
C1) derivatives can be made to target SaNanK and not the
human bifunctional enzyme, where the Zn-binding motif
occludes larger derivative.
Conclusions
Gram-positive NanK enzymes are annotated as ROK
enzymes, but many are missing the identifying ROK Zn-bind-
ing motif and have tyrosine in place of the histidine in the
EXGHmotif. Here we investigate the effect of these changes on
the structure and function of SaNanK.We focus ondefining the
role of tyrosine that replaces EXGH motif histidine and
provide insight into the presence or absence of Zn in ROK
kinases.
We report the first functional and structural study of aGram-
positive NanK. The crystal and solution structures conform to
the RNase H-like–fold present in ROK family proteins (36) and
we confirm that the enzyme is catalytically active as a kinase.
Therefore, SaNanK has the properties expected from a ROK
kinase. Investigation of the protein dynamics reveal the struc-
ture condenses with sugar substrate in the X-ray crystal form,
as reported for other ROKkinases (16, 31). For the first time, we
confirm this in solution with small-angle X-ray scattering
experiments.
Our sequence alignment reports that Gram-positive
NanK without the Zn-binding motif have tyrosine in place of
EXGH motif histidine. Structural and functional analysis
reveals that tyrosine binds C2 N-acetyl of N-acetylman-
nosamine by tilting backward from the active site. This is
substantially different from Zn-binding NanK, where the
EXGH motif histidine binds C1 and is restrained in a for-
ward-facing tilt by secondary binding of Zn. As EXGH motif
histidine binds Zn, the use of tyrosine in Gram-positive
NanK is certainly linked to the loss of Zn-binding. However,
as Gram-positive NanK are highly divergent at a sequence
level, it is difficult to know whether change of histidine from
the EXGH motif or Zn-binding motif residues occurred
first.
The role of the Zn-binding motif is not well-understood,
therefore the significance of its absence inGram-positiveNanK
is unknown. Our examination considered the absence of Zn-
binding in SaNanK and its presence in canonical ROK. A role
hypothesized for Zn-binding is that it organizes the active site
residues for catalysis (16). We find a possibly equivalent coor-
dinating feature in SaNanK: an arginine stack that is novel to
Staphylococcus. Loss of this feature in SaNanK lowered thermal
stability and significantly lowered catalytic rates, consistent
with the hypothesis that it is a feature that provides structural
stabilization and active site coordination, as opposed to being
provided by that Zn-binding in other ROK kinases. Our struc-
tural comparison also revealed that absence of the motif pro-
vides an opening at the sugar substrate active site. This is ben-
eficial for the active site access of larger substrates, such as
N-acetylmannosamine in SaNanK and potentially, disaccha-
ride cellobiose kinases (23). Whereas Zn-binding in E. coli
NanK requires increased hinge flexibility for N-acetylman-
nosamine association (19).We propose that the ROK Zn-bind-
ing motif is an adaptation that excludes large substrates, con-
sistent with ROK repressors and kinases generally functioning
with small sugars (13) that may also contribute to compulsory-
ordered catalysis for pathway regulation (16, 24). Finally, given
the proximity of the arginine stack andEXGYmotif, we propose
that this is a unique substructure to target with inhibitory com-




To provide a root for the phylogenetic tree of NanK protein
sequences, sequences for glucokinase, fructokinase, and
GlcNAc kinase enzymes that were closely related to the canon-
ical ROK sequence were added to the alignment. To select the
root sequences, the ROK Hidden Markov Model (HMM)
sequence from the Pfam database (https://pfam.xfam.org/
family/PF00480/hmm)4 was entered into pBLAST (https://
blast.ncbi.nlm.nih.gov/Blast.cgi), alongside the search terms
“glucokinase,” “fructokinase,” or “GlcNAc kinase.” The top
three sequence results (from unique genera) were included in
the alignment. NanK protein sequences were searched for by
inputting the SaNanK sequence, ROK HMM sequence, and
E. coli NanK sequence, alongside the search term “N-acetyl-
mannosamine kinase” into the tBLASTn database. The first
NanK sequence for each unique genus were added to the align-
ment. Additionally, sequences that had a different variation of
EXGH motif or Zn-binding residues, were included. To verify
sequences were annotated correctly, only sequences clustered
with Nan genes were included.
Cloning, expression, and purification
SaNanK-R164A, -R164K, and -Y160A were constructed
by Genscript based on variation of the SaNanK (accession
number YP_498886.1) codon optimized for expression in
E. coli. SaNanK-R164Awas synthesized de novo and inserted
into a pET30SE plasmid between NdeI and HindIII restric-
tion sites. SaNanK-R164K was then created by site-directed
mutagenesis.
SaNanK-Y160F was obtained by in-house site-directed
mutagenesis of the pET30SE-SaNanK (17, 37) using the infu-
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
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sion protocol (38), with forward primer (5-A GTT GGG TTT
TTA TTG TAT CGT CCA ACT GAA AA-3) and reverse
primer (5-AA TAA AAA CCC AAC TTC ATT TGC CTT
ATGA-3). Constructs were verified throughDNA sequencing
by Macrogen (Korea).
The protocol for expression and purification of WT protein
has previously been reported (17). Briefly, E. coli BL21 (DE3)
cells were transformedwith pET30SE/NanK, then cultured in
Luria-Broth containing kanamycin (30 g ml1) at 37 °C, 180
rpm until anOD600 of 0.6 was reached. Expression was induced
with isopropyl -D-1-thiogalactopyranoside at a final concen-
tration of 1 mM and incubated overnight at 26 °C. Purification
was conducted at 4 °C. Cells were harvested at 6,000 	 g for 10
min using a Thermo Sorvall RC-6-Plus centrifuge and resus-
pended in 20 mM Tris-HCl, pH 8.0. The cells were lysed for 10
min (Hielscher UP200S Ultrasonic Processor at 70%, 0.5 s
on/off cycle) and lysate containing soluble protein was
extracted from the supernatant after centrifugation at 24,000	
g. For anion exchange chromatography, the sample was applied
to a 20-ml Q-Sepharose anion exchange column (GE Health-
care) pre-equilibrated with lysis buffer, then eluted with an
increasing concentration gradient of 20mMTris-HCl, pH 8.0, 1
M NaCl. For hydrophobic exchange chromatography, ammo-
nium sulfate was added to the eluted protein to a final concen-
tration of 1 M and applied to a 20-ml Phenyl-Sepharose FF col-
umn (GE Healthcare) pre-equilibrated with 20 mM Tris-HCl,
pH 8.0, 1 M ammonium sulfate and eluted using an increasing
concentration gradient of 20 mM Tris-HCl, pH 8.0. Finally, size
exclusion chromatographywas conductedwith aHiLoad 16/60
Superdex 200 column (GE Healthcare) using 20 mM Tris-HCl,
pH 8.5. Final purity was estimated using SDS-PAGE gels (Fig.
S13). Exceptions to this procedure were as follows; sel-
enomethionine-substituted protein was produced using
PASM-5052 autoinduction media (39) and expression trials
of R164A mutants were conducted at 20 and 26 °C, for 4, 8,
and 16 h.
Enzyme kinetics
Initial rate data were recorded using a pyruvate kinase/lac-
tate dehydrogenase-coupled assay (19). NADH oxidation was
monitored using a CARY 100 Bio UV-visible spectrophotome-
ter (Agilent Technologies) based on an extinction coefficient of
6220M1 cm1 at 340 nm (40). The reactionmixture incubated
for 15 min at 25 °C consisted of a pyruvate kinase/lactate dehy-
drogenase mixture (10 l, purchased from Sigma SKU-P0294),
purified WT SaNanK, 0.017 mg ml1, 536 nM (10 l), 50 mM
phosphoenolpyruvate (20l), 8 mMNADH (20l), ATP varied
concentration (20 l), and kinetics buffer, 22 mM Tris-HCl, pH
8.5, 20 mM KCl, 5 mM MgCl2 (900 l), listed values are initial
concentrations. The reaction was initiated with sugar substrate
(20 l, at varied concentration), which was also incubated at
25 °C. To ensure that the N-acetylmannosamine kinase con-
centration was directly proportional with the rate, it was
checked that the coupling enzymes were in excess and that
there was no background reaction. The enzyme appeared to be
less stable when incubated at 30 °C or above, which was consis-
tent with a differential scanning fluorimetry experiment dem-
onstrating that the melting temperature of SaNanK is 39.5 °C
(Fig. 7C). Moreover, the enzyme was deactivated when in Tris-
HCl buffer at pH 8 or below. The data were processed using
GraphPad Prism 6.0 (GraphPad Software, La Jolla, CA). The
model that best fitted the data (ternary complex (Equation 1) or
substituted complex models (Equation 2)) was determined by
evaluating the AICc values (41) (ternary complex  129.8, sub-
stituted complex  203.4). Single substrate (apparent) kinetic
parameters were determined using the Michaelis-Menten
model.








KmBa 	 KmAb 	 ab
(Eq. 2)
Analytical ultracentrifugation
Analytical ultracentrifugation was performed using an XL-I
analytical ultracentrifuge (Beckman Coulter) at 50,000 rpm at
20 °C. Sedimentation velocity experiments were conducted
with N-acetylmannosamine kinase at 0.3, 0.6, and 0.9 mg ml1
(9.5, 18.9, and 28.4 M), in 20 mM Tris-HCl, pH 8.5, 100 mM
KCl. Sample (380 l) and reference buffer (400 l) were loaded
into 12-mm double-sector quartz cells with standard Epon
2-channel centerpieces and mounted in an An-50 Ti 8-hole
rotor (Beckman). Radial absorbance wasmeasured at 280 nm
with a step size of 0.003 cm over 80 scans. SEDNTERP soft-
ware was used to calculate values for solvent density and
solvent viscosity and to estimate partial specific volume,
based on the amino acid sequence (43). SEDFIT was then
used to fit the data with continuous size distribution (c(s))
and continuous mass distribution (c(M)) models (28). Resid-
uals were examined to review that noise was normally dis-
tributed and data points were checked for fit with curves
(Fig. S4).
Small angle X-ray scattering
Small angle X-ray scattering was undertaken at the Austra-
lian Synchrotron on the SAXS/WAXS beamline equipped with
a PILATUS 1M detector (170 	 170 mm, effective pixel size
172 	 172 m), as described by Griffin et al. (44). The X-ray
wavelength provided was 1.0332 Å and the sample detector
distance was set at 1600 mm, which produced a q range of
0.006–0.4 Å1. SaNanK (6 mg ml1, 189 M, 50 l) was
injected onto an inline Superdex 200 5/150GL (GEHealthcare)
using a co-flow setup (61). The columnwas equilibratedwith 20
mMTris-HCl, pH 8.0, 100mMNaCl and the radical scavengers,
5% (v/v) glycerol and 0.1% (w/v) sodium azide, using a flow rate
of 0.45 ml min1. Additionally, 5 mM N-acetylmannosamine
was added to the equilibration buffer above for the sugar-bound
sample. Over the course of the elution, scattering data were
collected in 1-s exposures using a 1.0-mm glass capillary at
12 °C.
To process the scattering data, ScatterBrain IDL (version
2.822, Australian Synchrotron Facility) was employed for initial
data reduction, radial integration of individual frames, and the
N-Acetylmannosamine kinase from S. aureus












































conversion of 1D data files. Data were buffer-subtracted using
CHROMIXS (45). TheATSAS software suite (version 2.8.0) was
used for all further analysis (29), including calculation of the
radius of gyration andpairwise distribution functionsP(r). The-
oretical scattering of the SaNanK crystal structures were calcu-
lated using CRYSOL (33).
X-ray crystallography
Crystallization was performed using the sitting-drop vapor-
diffusion method at 20 °C. For selenomethioinine-substituted
SaNanK, drops were composed of 10 mg ml1 of enzyme (200
nl) and reservoir solution (200 nl) containing 0.2M sodiummal-
onate dibasic monohydrate, 20% (w/v) PEG 3350 (Molecular
Dimensions, PACT premierHT-96 Screen, condition E12). For
N-acetylmannosamine– and GlcNAc–bound enzyme, drops
contained SaNanK 10 mg ml1 and either N-acetylman-
nosamine or GlcNAc 10 mM (200 nl), plus a reservoir solution
of 0.2 M L-arginine, 0.1 M sodium acetate, pH 5.0, in 8% (w/v)
poly--glutamic acid (200 nl) (Molecular Dimensions, PGA
HT-96 Screen, conditionA8). The crystals were cryo-protected
by soaking in 15% ethylene glycol solution and reservoir solu-
tion prior to freezing in liquid nitrogen.
The Australian Synchrotron MX1 and MX2 beamlines were
used for data collection. Data collected for the selenomethio-
nine-substituted enzymewas processed using iMosflm (46) and
AIMLESS (47). For enzyme with N-acetylmannosamine and
GlcNAc, data were processed with XDS and AIMLESS (47).
X-ray diffraction parameters are reported in Table 2.
Experimental phasing was conducted using anomalous scat-
tering of SaNanK from selenium-derivatized methionine (6
sites per monomer). The diffraction data were phased using
single anomalous diffraction processed by SHELXC/D/E,
including automated model building (26). Electron density of
the final resolved phases are demonstrated in Fig. S3. Phases of
N-acetylmannosamine– and GlcNAc–bound SaNanK were
calculated using the ligand-free SaNanK structure as a molec-
ular replacement model withMOLREP (48). Models were iter-
atively refined and built, using REFMAC5 and COOT (49, 50).
Finalization and model validation was conducted using phe-
nix.refine andMOLPROBITY (51, 52).
Attempts to solve the phases of ligand-free nonselenome-
thionine-substituted SaNanK using molecular replacement
were unsuccessful. Search models for SaNanK were selected
based on the highest sequence identity: 2GUP, 3VOV, 3VGK,
and 4HTL (identity  28.0–24.6%). Additionally, two NanK
structures were also trialled, PDB 2YHY and 2AA4 (identity 
21.9–21.4%). The models were split into monomeric units and
processed withCHAINSAW, to generate the searchmodel, and
molecular replacement was attempted using MOLREP and
PHASER (48, 53). We also tried partial models and lower pack-
ing restraints (54), but these were also unsuccessful.
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